David A. Hormuth, II

Research Scientist | Biomedical Engineering + Imaging Science > > Computational Oncology

Towards an Image-Informed Mathematical Model of In Vivo Response to Fractionated Radiation Therapy


Journal article


D. Hormuth, Angela M. Jarrett, Tessa Davis, T. Yankeelov
Cancers, 2021

Semantic Scholar DOI PubMedCentral PubMed
Cite

Cite

APA   Click to copy
Hormuth, D., Jarrett, A. M., Davis, T., & Yankeelov, T. (2021). Towards an Image-Informed Mathematical Model of In Vivo Response to Fractionated Radiation Therapy. Cancers.


Chicago/Turabian   Click to copy
Hormuth, D., Angela M. Jarrett, Tessa Davis, and T. Yankeelov. “Towards an Image-Informed Mathematical Model of In Vivo Response to Fractionated Radiation Therapy.” Cancers (2021).


MLA   Click to copy
Hormuth, D., et al. “Towards an Image-Informed Mathematical Model of In Vivo Response to Fractionated Radiation Therapy.” Cancers, 2021.


BibTeX   Click to copy

@article{d2021a,
  title = {Towards an Image-Informed Mathematical Model of In Vivo Response to Fractionated Radiation Therapy},
  year = {2021},
  journal = {Cancers},
  author = {Hormuth, D. and Jarrett, Angela M. and Davis, Tessa and Yankeelov, T.}
}

Abstract

Simple Summary Using medical imaging data and computational models, we develop a modeling framework to provide personalized treatment response forecasts to fractionated radiation therapy for individual tumors. We evaluate this approach in an animal model of brain cancer and forecast changes in tumor cellularity and vasculature. Abstract Fractionated radiation therapy is central to the treatment of numerous malignancies, including high-grade gliomas where complete surgical resection is often impractical due to its highly invasive nature. Development of approaches to forecast response to fractionated radiation therapy may provide the ability to optimize or adapt treatment plans for radiotherapy. Towards this end, we have developed a family of 18 biologically-based mathematical models describing the response of both tumor and vasculature to fractionated radiation therapy. Importantly, these models can be personalized for individual tumors via quantitative imaging measurements. To evaluate this family of models, rats (n = 7) with U-87 glioblastomas were imaged with magnetic resonance imaging (MRI) before, during, and after treatment with fractionated radiotherapy (with doses of either 2 Gy/day or 4 Gy/day for up to 10 days). Estimates of tumor and blood volume fractions, provided by diffusion-weighted MRI and dynamic contrast-enhanced MRI, respectively, were used to calibrate tumor-specific model parameters. The Akaike Information Criterion was employed to select the most parsimonious model and determine an ensemble averaged model, and the resulting forecasts were evaluated at the global and local level. At the global level, the selected model’s forecast resulted in less than 16.2% error in tumor volume estimates. At the local (voxel) level, the median Pearson correlation coefficient across all prediction time points ranged from 0.57 to 0.87 for all animals. While the ensemble average forecast resulted in increased error (ranging from 4.0% to 1063%) in tumor volume predictions over the selected model, it increased the voxel wise correlation (by greater than 12.3%) for three of the animals. This study demonstrates the feasibility of calibrating a model of response by serial quantitative MRI data collected during fractionated radiotherapy to predict response at the conclusion of treatment.


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in